BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11111915)

  • 1. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
    Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.
    Zhang Y; Barbieri JT
    Infect Immun; 2005 Dec; 73(12):7938-45. PubMed ID: 16299285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
    Maresso AW; Riese MJ; Barbieri JT
    Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADP-ribosylation of cyclophilin A by Pseudomonas aeruginosa exoenzyme S.
    DiNovo AA; Schey KL; Vachon WS; McGuffie EM; Olson JC; Vincent TS
    Biochemistry; 2006 Apr; 45(14):4664-73. PubMed ID: 16584201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
    Pederson KJ; Krall R; Riese MJ; Barbieri JT
    Mol Microbiol; 2002 Dec; 46(5):1381-90. PubMed ID: 12453223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    Goehring UM; Schmidt G; Pederson KJ; Aktories K; Barbieri JT
    J Biol Chem; 1999 Dec; 274(51):36369-72. PubMed ID: 10593930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
    Krall R; Sun J; Pederson KJ; Barbieri JT
    Infect Immun; 2002 Jan; 70(1):360-7. PubMed ID: 11748202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility.
    Takaishi K; Sasaki T; Kato M; Yamochi W; Kuroda S; Nakamura T; Takeichi M; Takai Y
    Oncogene; 1994 Jan; 9(1):273-9. PubMed ID: 8302589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
    Maresso AW; Baldwin MR; Barbieri JT
    J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin.
    Deng Q; Zhang Y; Barbieri JT
    Traffic; 2007 Oct; 8(10):1331-45. PubMed ID: 17714437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.
    Rocha CL; Coburn J; Rucks EA; Olson JC
    Infect Immun; 2003 Sep; 71(9):5296-305. PubMed ID: 12933877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of exoenzyme S residues that mediate the interaction with 14-3-3 and its biological activity.
    Yasmin L; Jansson AL; Panahandeh T; Palmer RH; Francis MS; Hallberg B
    FEBS J; 2006 Feb; 273(3):638-46. PubMed ID: 16420486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.